Probiyotik Olarak Tanımlanan Yeni Mikroorganizmalar
Tarih boyunca insanlar tarafından canlı mikroorganizmalar içeren bitkisel ve hayvansal orijinli fermente gıdalar
Novel Microorganisms Accepted as Probiotics
Throughout history, fermented foods from vegetable and animal origin including live microorganisms have been consumed by humans. In traditional fermented foods, natural microorganisms, called probiotics, are defined as live microorganisms that benefit the host when administered in sufficient amounts. Everyday, new bacteria, which are isolated from natural sources or derived from the current strains of bacteria, are discovered and therefore probiotic assessments and reliability of these bacteria should be investigated in depth. Recent samples of microorganisms requir-ing detailed examination are Leuconostoc mesenteroides, Bacillus subtilis natto, Clostridium butyricum, Bacteroides xylanisolvens, Akkermansia muciniphila, Fructophilic lactic acid bacteria (FLAB) and aecalibacterium prausnitzii. In this review, it is aimed to give information about some new microorganisms which have probiotic properties.
___
- Alcantara-Hernandez RJ, Rodriguez-Alvarez JA, Valenzuela-
Encinas C, Gutierrez-Miceli FA, Castanon-Gonzalez H,
Marsch R, Ayora-Talavera T, Dendooven L, (2010).
The bacterial community in ’taberna’ a traditional beverage of
Southern Mexico. Lett Appl Microbiol. 51, 558–563.
- Anonim, (2001). European Commission. E. Commission:
2001/122/EC. Commission Decision of 30 January 2001
on Authorising the Placing on the Market of a Dextran
Preparation Produced by Leuconostoc mesenteroides as a
Novel Food Ingredient in Bakery Products under Regulation
(EC) No 258/97 of the European Parliament and of the Council
(Notified Under Document Number C(2001) 174). Erişim ad-
resi; https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri
=CELEX:32001D0122&from=HR, Erişim tarihi: 01.12.2018.
- Anonim, (2007). Introduction of a Qualified Presumption
of Safety (QPS) Approach for Assessment of Selected
Microorganisms Referred to EFSA - Opinion of the Scientific
Committee. Erişim adresi: https://efsa.onlinelibrary.wiley.com/
doi/epdf/10.2903/j.efsa.2007.587, Erişim tarihi: 30.11.2018
- Anonim, (2014). European Commission. E. Commission:
2014/907/EU. Commission Implementing Decision of 11
December 2014 Authorising the Placing on the Market of
Clostridium butyricum (CBM 588) as a Novel Food Ingredient
under Regulation (EC) No 258/97 of the European Parliament
and of the Council (Notified Under Document C(2014) 9345).
Erişim adresi: https://eur-lex.europa.eu/legal-content/EN/
TXT/PDF/?uri=CELEX:32014D0907&from=EN, Erişim tar-
ihi: 01.12.2018.
- Arias AC, Murray BE, (2010). Enterococcus species,
Streptococcus bovis group, and Leuconostoc species. Mandell
GL, Bennett JE, Dolin R. eds. Principles and practice of
Infectious Diseases. 7th ed. Churchill Livingstone Elsevier Inc,
Philadelphia, USA. p.2643-2653.
- Asama T, Arima TH, Gomi T, Keishi T, Tani H, Kimura Y,
Tatefuji T, Hashimoto K, (2015). Lactobacillus kunkeei YB38
from honeybee products enhances IgA production in healthy
adults. J Appl Microbiol. 119, 818–826.
- Asama T, Kimura Y, Kono T, Tatefuji T, Hashimoto K, Benno
Y, (2016). Effects of heat-killed Lactobacillus kunkeei YB38
on human intestinal environment and bowel movement: a pilot
study. Benef Microbes. 7, 337–344.
- Breyner NM, Michon C, de Sousa CS, Vilas Boas PB, Chain
F, Azevedo V, Langella P, Chatel JM, (2017). Microbial Anti-
Inflammatory Molecule (MAM) from Faecalibacterium praus-
nitzii shows a protective effect on DNBS and DSSinduced coli-
tis model in mice through inhibition of NF-kappaB pathway.
Front Microbiol. 8, 114.
- Brodmann T, Endo A, Gueimonde M, Vinderola G, Kneifel W,
De Vos WM, Salminen S, Gomez-Gallego C, (2017). Safety of
Novel Microbes for Human Consumption: Practical Examples
of Assessment in the European Union. Front Microbiol. 8,
1725.
- Cammarota G, Ianiro G, Bibbo S, Gasbarrini A, (2014). Gut
microbiota modulation: probiotics, antibiotics or fecal micro-
biota transplantation? Intern Emerg Med. 9, 365–373.
- Chassard C, Delmas E, Lawson PA, Bernalier-Donadille A,
(2008). Bacteroides xylanisolvens sp. nov., a xylan-degrad-
ing bacterium isolated from human faeces. Int J Syst Evol
Microbiol. 58(Pt 4), 1008–1013.
- Cibik R, Lepage E, Talliez P, (2000). Molecular diversity of leu-
conostoc mesenteroides and leuconostoc citreum isolated from
traditional french cheeses as revealed by RAPD fingerprinting,
16S rDNA sequencing and 16S rDNA fragment amplification.
Syst Appl Microbiol. 23, 267–278.
- Ciprandi G, Scordamaglia A, Venuti D, Caria M, Canonica GW,
(1986). In vitro effects of Bacillus subtilis on the immune re-
sponse. Chemioterapia. 5, 404–407.
- Collado MC, Laitinen K, Salminen S, Isolauri E, (2012).
Maternal weight and excessive weight gain during pregnancy
modify the immunomodulatory potential of breast milk. Pediatr
Res. 72, 77–85.
- . Costello EK, Gordon JI, Secor SM, Knight R, (2010).
Postprandial remodeling of the gut microbiota in Burmese py-
thons. ISME J. 4, 1375–1385.
- . D’Angelo L, Cicotello J, Zago M, Guglielmotti D, Quiberoni A,
Suarez V, (2017). Leuconostoc strains isolated fromdairy prod-
ucts: response against food stress conditions. Food Microbiol.
66, 28–39.
- Demoss RD, Bard RC, Gunsalus IC, (1951). The mechanism of
heterolactic fermentation: a new route of ethanol formation. J
Bacteriol. 62, 499-511.
- Derrien M, Collado MC, Ben-Amor K, Salminen S, De Vos
WM, (2008). The mucin degrader Akkermansia muciniphila
is an abundant resident of the human intestinal tract. Appl
Environ Microbiol. 74, 1646–1648.
- Derrien M, van Passel MWJ, van de Bovenkamp JHB,
Schipper RG, de Vos WM, Dekker J, (2010). Mucin-bacterial
interactions in the human oral cavity and digestive tract. Gut
Microbes. 1, 254–268.
- . EFSA Panel on Biological Hazards, (2010). Scientific Opinion
on the maintenance of the list of QPS biological agents inten-
tionally added to food and feed. EFSA J. 8, 1–56.
- EFSA Panel on Dietetic Products, Nutrition and Allergies,
(2015). Scientific Opinion on the safety of ‘heat-treated milk
products fermented with Bacteroides xylanisolvens DSM
23964’ as a novel food. EFSA J. 13, 1–18.
- Endo A, Futagawa-Endo Y, Dicks LM (2009). Isolation and
characterization of fructophilic lactic acid bacteria from fruc-
tose-rich niches. Syst Appl Microbiol. 32, 593–600.
- . Endo A, Irisawa T, Futagawa-Endo Y, Takano K, du Toit M,
Okada S, Dicks LM, (2012a). Characterization and emended
description of Lactobacillus kunkeei as a fructophilic lactic
acid bacterium. Int J Syst Evol Microbiol. 62, 500–504.
- . Endo A, (2012b). Fructophilic lactic acid bacteria inhabit fruc-
tose-rich niches in nature. Microb Ecol Health Dis. 23, 6–12.
- Endo A, Tanizawa Y, Tanaka N, Maeno S, Kumar H, Shiwa Y,
Okada S, Yoshikawa H, Dicks L, Nakagawa J, Arita M, (2015).
Comparative genomics of Fructobacillus spp. and Leuconostoc
spp. reveals niche-specific evolution of Fructobacillus spp.
BMC Genomics. 16, 1117.
- Foditsch C, Santos TM, Teixeira AG, Pereira RV, Dias JM,
Gaeta N, Bicalho RC, (2014). Isolation and characterization
of Faecalibacteriumprausnitzii from calves and piglets. PLoS
ONE. 9, e116465
- Ghoddusi HB, Sherburn R, (2010). Preliminary study on the
isolation of Clostridium butyricum strains from natural sourc-
es in the UK and screening the isolates for presence of the type
E botulinal toxin gene. Int J Food Microbiol. 142, 202–206.
- Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ,
Brummer RJ, (2008). The role of butyrate on colonic function.
Aliment Pharmacol Ther. 27, 104–119.
- Handweger S, Horowitz H, Coburn Kenneth, Kolokathis A,
Wormser PG, (1990). Infection due to Leuconostoc species;
Six cases and Review. Clin Infect Dis. 12, 602-610.
- Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot
B, Morelli L, Canani RB, Flint HJ, Salminen S, Calder PC,
Sanders ME, (2014). The International Scientific Association
for Probiotics and Prebiotics consensus statement on the
scope and appropriate use of the term probiotic. Nat Rev
Gastroenterol Hepatol. 11, 506–514.
- Ishiyama K, Yamazaki H, Senda Y, Yamauchi H, Nakao S,
(2011). Leuconostoc bacteremia in tree patients with malig-
nancies. J Infect Chemother. 17, 412-418.
32. Jiang H, Ling Z, Zhang Y, Mao H, Ma Z, Yin Y, Wang W, Tang
W, Tan Z, Shi J, Li L, Ruan B, (2015). Altered fecal microbiota
composition in patients with major depressive disorder. Brain
Behav Immun. 48, 186–194.
- Kim D, Day DF, (1994). A new process for the production of
clinical dextran by mixed-culture fermentation of Lipomyces
starkeyi and Leuconostoc mesenteroides. Enzyme Microb
Technol. 16, 844-848.
- Koneman EW, Allen SD, Janda WM, Schreckenberger PC,
Winn WC Jr, eds., (1997). Koneman’s Color Atlas and Textbook
of Diagnostic Microbiology. Fifth edition. Philadelphia:
Lippincott, p.577-650.
- . Leathers TD, Hayman GT, Cote GL, (1995). Rapid Screening of
Leuconostoc mesenteroides Mutants for Elevated Proportions
of Alternan to Dextran. Current Microbiol. 31, 19-22.
- Leuschner RGK, Robinson TP, Hugas M, Cocconcelli PS,
Richard- Forget F, Klein G, Licht TR, Nguyen-The C, Querol
A, Richardson M, Suarez JE, Thrane U, Vlak JM, von Wright
A, (2010). Qualified presumption of safety (QPS): a generic
risk assessment approach for biological agents notified to the
European Food Safety Authority (EFSA). Trends Food Sci
Technol. 21, 425–435.
- Miquel S, Martin R, Rossi O, Bermudez-Humaran LG, Chatel
JM, Sokol H, Thomas M, Wells JM, Langella P, (2013).
Faecalibacteriumprausnitzii and human intestinal health. Curr
Opin Microbiol. 16, 255–261.
38. Nakano MM, Zuber P, (1998). Anaerobic growth of a “strict
aerobe” (Bacillus subtilis). Annu Rev Microbiol. 52, 165–90.
- Neveling DP, Endo A, Dicks LM, (2012). Fructophilic
Lactobacillus kunkeei and Lactobacillus brevis isolated from
fresh flowers, bees and bee-hives. Curr Microbiol. 65, 507–515.
40. Ouwerkerk JP, van der Ark KC, Davids M, Claassens NJ,
Robert Finestra T, de Vos WM, Belzer C, (2016). Adaptation
of Akkermansia muciniphila to the oxic-anoxic interface of the
mucus layer. Appl Environ Microbiol. 82, 6983–6993.
- Plovier H, Everard A, Druart C, Depommie, C, Van Hul M,
Geurts L, Chilloux J, Ottman N, Duparc T, Lichtenstein L,
Myridakis A, Delzenne NM, Klievink J, Bhattacharjee A, van
der Ark KC, Aalvink S, Martinez LO, Dumas ME, Maiter
D, Loumaye A, Hermans MP, Thissen JP, Belzer C, de Vos
WM, Cani PD, (2017). A purified membrane protein from
Akkermansia muciniphila or the pasteurized bacterium im-
proves metabolism in obese and diabetic mice. Nat Med. 23,
107–113.
- Rainey FA, (2009). Genus I. Clostridium Prazmowski 1880.
Vos P, Garrity G, Jones D, Krieg NR, Ludwig W, Rainey FA,
eds. Bergey’s Manual of Systematic Bacteriol: volume 3 The
Firmicutes. 9th ed., Springer, New-York. p.739–740
43. Roeselers G, Mittge EK, Stephens WZ, Parichy DM, Cavanaugh
CM, Guillemin K, Rawls JF, (2011). Evidence for a core gut
microbiota in the zebrafish. ISME J. 5, 1595–1608.
- Sato R, Tanaka M, (1997). Intestinal distribution and intralumi-
nal localization of orally administered Clostridium butyricum
in rats. Microbiol Immunol. 41, 665–671.
- Schlegel HG (1993). General Microbiology. Seventh edition.
Cambridge: CU Press, p.193-233.
- . Sears CL, (2005). A dynamic partnership: celebrating our gut
flora. Anaerobe. 11, 247–251.
- . Selhub EM, Logan AC, Bested AC, (2014). Fermented foods,
microbiota, and mental health:ancient practice meets nutri-
tional psychiatry.J Physiol Anthropol. 33.
- Server-Busson C, Foucaud C, Leveau JY, (1999). Selection
of Dairy Leuconostoc Isolates for Important Technological
Properties. J Dairy Res. 66, 245-56.
- Shang H, Sun J, Chen YQ, (2016). Clostridium butyricum
CGMCC0313.1 modulates lipid profile, insulin resistance and
colon homeostasis in obese mice. PLoS ONE. 11, e0154373.
- Shimbo I, Yamaguchi T, Odaka T, Nakajima K, Koide A,
Koyama H, Saisho H, (2005). Effect of Clostridium butyri-
cum on fecal flora in Helicobacter pylori eradication therapy.
World J Gastroenterol. 11,7520–7524.
- Ulsemer P, Toutounian K, Schmidt J, Karsten U, Goletz S,
(2012). Preliminary safety evaluation of a new Bacteroides xyl-
anisolvens isolate. Appl Environ Microbiol. 78, 528–535.